1. The antiviral activity of Isoprinosine
- Author
-
Eric R. Brown and Paul Gordon
- Subjects
Immunology ,Antiviral Agents ,Applied Microbiology and Biotechnology ,Microbiology ,Virus ,Adenoviridae ,Cell Line ,Mice ,chemistry.chemical_compound ,Tissue culture ,In vivo ,Influenza, Human ,Inosine pranobex ,Genetics ,Animals ,Humans ,RNA, Messenger ,Lung ,Molecular Biology ,Herpesviridae ,Messenger RNA ,biology ,RNA ,Haplorhini ,Herpesviridae Infections ,General Medicine ,Orthomyxoviridae ,biology.organism_classification ,Amino Alcohols ,Virology ,Inosine ,Poliovirus ,Titer ,Animals, Newborn ,chemistry ,Female - Abstract
A hypothesis predicting that increase in the rate of synthesis of host messenger RNA would be associated with antiviral activity was examined. Biochemically, Isoprinosine or NPT-10381 (methisoprinol) increased the rate of rapid labeling of polyribosomal RNA and protein in uninfected monkey kidney cells in tissue culture. In tissue-culture systems, Isoprinosine exerted antiviral effects against influenza virus, PR-8 and A2 strains; herpes virus, LU strain; polio virus 3; and adenovirus 10. In in vivo mortality studies, Isoprinosine was observed to exert therapeutic antiviral effects against the A2 strain of influenza and, as well, against a herpes infection of newborn mice. Experiments were carried out which demonstrated a correlation between the in vivo anti-influenza (PR-8) effects of Isoprinosine and reduction in the virus titer in lungs of infected mice.
- Published
- 1972
- Full Text
- View/download PDF